特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪粉e r们，今天是高薪精品仪器职位专辑，有不少 新的雇主 哦！ 销售精英，热招职位 Ho t r e c r u itme n t p o siti o n s 为仪科技有限公司 销售总监 长沙- 2 5 k - 5 0 k · 1 2薪 岗位要求： 本科及以上学历，材料科学、化学、市场营销等相关专业优先；5年以上科学仪器或高端设备行业销售经验，其中3年以上销售团队 管理经验；熟悉热分析仪器（如量热，DSC，TG，STA等）者优先。 瑞士步琦公司 天津-面议 岗位要求： 研究生或以上学历；熟悉近红外，在线近红外技术，并从事过NIR应用开发或技术支持或销售工作。 Re st ek 瑞思泰康 销售工程师 济南- 1 0 k - 2 0 k · 1 2薪 岗位要求： 化学、分析化学、生物、食品等专业大专以上学历；有食品、环境、制药、化工等相关行业3年以上的色谱销售经验。 北京普立泰科仪器有限公司 销售工程师 杭州- 1 0 k - 1 5 k · 1 2薪 岗位要求： 本科以上学历，化工类 ...

导读： 国产替代不仅打破技术垄断，更推动产业从"Me too"向"Me better"甚至"Me different"跃迁，为中国生命科学设备的自主可控奠定基础。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 "国产好仪器"已走过十个年头，我们始终坚持以"用户说好才是真的好"为不变的原则，以用户长期使用的真实反馈为基础，从上千台候选仪器 中，精心甄选出400多款品质卓越、性能稳定的国产佳品。 为了更好地倾听用户的心声，"国产好仪器"再度升级，通过更加深入和有针对性的用户调研，寻找满足用户需求的"国产好仪器"，助力仪器用 户从海量信息中找到"对"的产品！ 参与方式： 只要您使用过海报中的仪器产品，长按识别下方海报中二维码参与调研就有机会获得奖品。 奖品设置： 凡参与调研的用户，即有机会抽取定制吸管玻璃杯；被认定为有效问卷的用户，还将获得15元话费奖励！ 欢迎各位相关用户参与调研，您的参与对我们的调研至关重要，感谢您的支持！ LET X 用户有奖调研 有机会获得 可获得 吸管玻璃杯 15元话费奖励 i人直答题并? 研 填写调研问卷的用户 有效 ...

Core Viewpoint - The company, Chuangyuan Xinke, is gaining institutional interest and has made significant advancements in low-altitude economy and 6G testing technologies, showcasing its strategic developments and future plans through various institutional engagements and performance briefings [1]. Group 1: Institutional Interest and Engagement - Chuangyuan Xinke has received attention from multiple institutions, including Western Securities, Dongwu Securities, and Founder Securities, with several meetings held in May 2023 [1]. - The company hosted an annual performance briefing on May 15, 2023, to present its technological breakthroughs and market strategies in low-altitude economy and 6G testing [1]. Group 2: Project Wins and Product Development - The company has successfully won a procurement project for key equipment from Tonghao Low-altitude Intelligent Technology Co., with a contract value of RMB 1.15 million for the mmWave 5G integrated testing system [2]. - The mmWave 5G system is part of the company's "1+3" development strategy, focusing on satellite internet and low-altitude economy communication testing products [2]. Group 3: Strategic Focus and Product Expansion - Chuangyuan Xinke's "1+3" strategy emphasizes communication testing in satellite internet and low-altitude economy, with new product launches such as the Rainbow series for low-altitude signal monitoring [3]. - The company has seen significant year-on-year growth in customer expansion and sales in the satellite internet testing sector, including the launch of low-orbit satellite payload certification testing systems [3]. Group 4: Collaboration and R&D Investment - The company is actively collaborating with Huawei on 5G/6G communication testing products, with ongoing projects in 6G technology development and product layout [4]. - Recent projects include the development of a high-bandwidth high-frequency channel simulator for 6G, which aims to enhance China's capabilities in advanced communication testing equipment [4]. - Chuangyuan Xinke has invested a total of RMB 491 million in R&D over the past three years, representing nearly 60% of its cumulative revenue during that period [5].

Core Points - The report details the change in equity ownership of Chongqing Chuan Yi Automation Co., Ltd, indicating an increase in control by Guoji Instrument and Meter (Chongqing) Co., Ltd, which will become the controlling shareholder [1][10] - The transaction involves the acquisition of 98,841,678 shares from China Fourlink Instrument Group, representing 19.26% of the total shares, and the delegation of voting rights for 54,668,322 shares from Yufu Holdings, accounting for 10.65% of the voting rights [10][12] - After the transaction, the information disclosure obligor will hold a total of 153,510,000 shares, corresponding to 29.91% of the voting rights, thus becoming the controlling shareholder of Chuan Yi [12][13] Summary by Sections Section 1: Introduction of the Information Disclosure Obligor - The information disclosure obligor is Guoji Instrument and Meter (Chongqing) Co., Ltd, with a registered capital of 200 million yuan and established on January 26, 2025 [4][5] - The controlling shareholder is China Machinery Industry Group Co., Ltd, which holds 100% of the shares of the information disclosure obligor [5][6] Section 2: Purpose and Decision-Making Process of the Equity Change - The purpose of the equity change is to optimize state-owned capital layout and enhance the development of the instrument and meter industry [10][12] - The decision-making process has been completed, and necessary approvals are being prepared [2][10] Section 3: Method of Equity Change - The equity change will be executed through a voting rights delegation and a share transfer agreement [12][13] - The share transfer involves a total payment of 2,392,584,200 yuan for the shares acquired from China Fourlink [19][20] Section 4: Financial Status of the Controlling Shareholder - The controlling shareholder, China Machinery Industry Group, reported total assets of approximately 33.37 billion yuan and net profit of about 599 million yuan for the year ending 2024 [7][8]

Core Viewpoint - The financial advisory opinion from China International Capital Corporation regarding the equity change report of Chongqing Chuan Yi Automation Co., Ltd. confirms that the equity change complies with relevant laws and regulations, and the information disclosed is accurate and complete [1][2][6]. Group 1: Financial Advisory Opinion - The financial advisor has no conflicts of interest with the equity change and has conducted due diligence to ensure the accuracy of the information provided [1][2]. - The financial advisor believes that the equity change aligns with legal requirements and that the information disclosed is truthful and complete, with no significant omissions [1][2][6]. - The financial advisor has verified that the contents of the equity change report comply with the relevant regulations [6][7]. Group 2: Company Information - The information disclosure obligor, Guojin Instrument (Chongqing) Co., Ltd., is a limited liability company with its legal representative being Zhou Kaizhu, registered in Chongqing [7][8]. - The controlling shareholder and actual controller of the information disclosure obligor is China Machinery Industry Group Co., Ltd., which holds 100% of the shares [9][10]. Group 3: Equity Change Details - The equity change involves Guojin Instrument acquiring 98,841,678 shares from the Four Union Group at a price of 24.206 yuan per share, representing 19.26% of the total shares of Chuan Yi [18][19]. - After the transaction, Guojin Instrument will hold a total of 153,510,000 shares, corresponding to 29.91% of the voting rights, making it the controlling shareholder of Chuan Yi [19][20]. Group 4: Financial Status - The financial status of the controlling shareholder, China Machinery Industry Group, shows total assets of approximately 33.37 billion yuan and net profit of approximately 599 million yuan for the year ending 2024 [13][19]. - The financial advisor confirms that the funds for the equity change will come from the self-owned or self-raised funds of the information disclosure obligor and its controlling shareholder, with no involvement from the listed company [22][23]. Group 5: Future Plans - The information disclosure obligor has no plans to change the main business or make significant adjustments in the next 12 months [23][24]. - There are no plans for asset sales, mergers, or significant changes in the management structure of the listed company in the near future [24][25].

从市场监管总局了解到，在国家重点研发计划"国家质量基础设施体系"重点专项支持下，由深圳市计量 质量检测研究院牵头研发的全球首套医用电子仪器全自动测试系统顺利通过验收。这是市场监管总局通 过大力支持NQI技术攻关、统筹推进我国医疗电子仪器产业科技创新与产业创新深度融合的实践成果， 对提升我国医疗仪器产业质量、提高国际竞争力具有重要现实意义。（央视） ...

o 生命科学和诊断市场集团（ LDG ） ： 第二季度营收为 6 . 5 4 亿美元，同比增长 8%，按核 心业务计算增长 3%，该板块本季度运营利润率为 1 9 . 7%。 导读： 安捷伦科技2025财年Q2营收16.7亿美元，同比增长6%，净利润3.73亿美元。生命科学和诊断市 场集团（LDG）收入同比增长8%。中国区总收入超10%。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 安捷伦科技公司于 2 0 2 5 年 5 月 2 8 日发布了 2 0 2 5 财年第二季度财报。 截 至 2 0 2 5 年 4 月 3 0 日的第二季度，公司营收为 1 6 . 7 亿美元，较 2 0 2 4 年同期增长 6 . 0%，按核心业务计算增 长 5 . 3% 。 生命科学和诊断市场集团（LDG）收入同比增长8%。中国区收入增长1 0%。 具体如下： • 净利润 ： 第二季度GAAP净利润为 2 . 1 5 亿美元，每股收益 0 . 7 5 美元；非 GAAP 净利润为 3 . 7 3 亿美元，每股收益 1 . 3 1 美元。2 0 2 4 ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪器信息网现正开展 "动态环境下基于资源的管理举措对组织韧性及创新的影响" 研究， 诚邀研发制造型中小企业决 策者参与调研，分享宝贵管理经验。本次调研由仪器信息网产业研究中心团队发起，旨在探索动态环境中企业资源管理 策略与组织韧性、创新能力之间的内在关联。您作为研发制造领域的实践者，在行业竞争与环境变化中积累的决策智 慧，将为构建本土化管理理论提供关键数据支撑，研究成果也将为同类企业应对市场挑战提供参考。 若您对研究成果感兴趣，可在问卷末尾 留下邮箱 ，研究完成后将 第一时间向您分享 研究成果 。 调研对象 ： 科学仪器 研发制造型中小企业决策者 调研内容与形式 ： 问卷内容 ： 问卷共分为三大部分，涵盖企业背景信息（业务类型、行业类别、规模等）、当前组织韧性与创新情况、 前一年环境动态性及信息管理状况。预计完成时间约 1 0 分钟。 隐私保护 ： 调研数据仅用于学术研究，将严格遵循保密原则，不涉及企业及个人敏感信息，您可放心作答。 如有任何疑问，可联系仪器信息网产业研究中心团队，感谢您的支持 ...

导读： 近日，Bio-Rad 通过邮件正式通知客户，公司即将实施关税附加费，但未披露关税附加费的具体数额。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，Bi o -Ra d首席执行官 No rma n Sc hwa rt z 与首席财务官 Ro o p K. La k k a r a j u 在2 0 2 5年 RBC 资本市场全球医疗 保健会议的炉边聊天活动中，分享了公司在复杂市场环境下的运营策略与未来展望。尽管面临诸多挑战，Bi o -Ra d仍展 现出积极应对的决心，凭借运营改进和战略收购等举措，力求实现稳健增长。 5月2 1日， Bi o -Rad 通过邮件正式通知客户，公司即将实施关税附加费，但未披露关税附加费的具体数额 。 这封邮件 由Bi o -Ra d美洲区商业运营高级副总裁Ry a n Sh o rt签署，信中写道："当前的全球贸易环境对整个行业带来了影响，全 球 关 税 的 激 增 已 对 Bi o -Ra d 产 品 的 制 造 造 成 影 响 。 " La k k a r a j u 指 出 ， 关 税 附 ...

Core Viewpoint - The Ministry of Industry and Information Technology has announced the preliminary list of the first batch of key cultivation pilot platforms, with a total of 242 platforms selected nationwide, covering essential fields for high-quality development in manufacturing [1][3]. Summary by Relevant Sections Pilot Platforms Overview - A total of 242 pilot platforms have been selected, categorized as follows: 79 in raw materials industry, 62 in consumer goods industry, 60 in equipment manufacturing, 21 in information technology, 13 in emerging and future industries, and 7 in common demand fields [3]. Equipment Manufacturing Sector - In the equipment manufacturing sector, 8 instrument and meter pilot platforms have been included, such as: - China Sensor Valley Intelligent Sensor Pilot Platform - Automotive Sensor Pilot Platform - Instrument Functional Materials and Special Sensors Pilot Platform - High-Precision Grating Scale Manufacturing and Application Pilot Platform - Nuclear Power Plant Instrument Pilot Platform - Beijing Jingyi High-End Instruments and Meters Pilot Platform - Guangdong Precision Instruments Advanced Manufacturing Technology Pilot Platform - Mechanical Industry Instrument Comprehensive Research Institute MEMS Sensor Pilot Platform [3][4]. Consumer Goods Industry - In the consumer goods industry, 33 pharmaceutical pilot platforms have been selected, including: - Liaoning Shangyao Northern Pharmaceutical Chemical Pilot Platform - Gene Engineering Drug Clinical Test Sample Preparation Pilot Platform - Innovative Drug Pilot Platform - Various medical device pilot platforms such as the West Lake IBT Biological Intelligence Pilot Platform and Regenerative Medicine Technology and Material Transformation Pilot Platform [5][6]. Medical Devices Sector - The medical devices sector includes 7 pilot platforms, such as: - West Lake IBT Biological Intelligence Pilot Platform - Medical Device Preclinical Animal Testing Safety Efficacy Verification and Inspection Testing Pilot Platform - Blood Dialysis Machine Pilot Platform - Beijing High-End Medical Device CDMO Pilot Platform - Regenerative Medicine Technology and Material Transformation Pilot Platform [7][8].